
Join to view full profile
2900 W Oklahoma AveMilwaukee, WI 53215
Phone+1 414-649-6000
Dr. Bugazia is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. AlBugazia is a pulmonologist specializing in critical care medicine, based in Milwaukee, WI. He completed a fellowship in critical care medicine at the Cleveland Clinic Foundation and a residency in internal medicine at the University of Toledo. He graduated in 2005 from the Garyounis University Faculty of Medicine. Currently, he works as an intensivist at Aurora Sinai Medical Center since 2019.
Education & Training
Cleveland Clinic FoundationFellowship, Critical Care Medicine, 2011 - 2013
University of ToledoResidency, Internal Medicine, 2008 - 2011
Garyounis University Faculty of MedicineClass of 2005
Certifications & Licensure
GA State Medical License 2026 - 2028
TN State Medical License 2025 - 2028
TX State Medical License 2023 - 2028
WI State Medical License 2013 - 2027
ID State Medical License 2020 - 2022
UT State Medical License 2020 - 2022
WA State Medical License 2017 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine- Join now to see all
Publications & Presentations
PubMed
- 2 citationsEfficacy and safety of ensifentrine in treatment of COPD: a systematic review and meta-analysis of clinical trials.Bara M Hammadeh, Osama M Younis, Muaath I Alsufi, Muhammad Idrees, Ayham Mohammad Hussein
Therapeutic Advances in Respiratory Disease. 2025-06-20
Press Mentions
US to Fund New Research into Potential PTSD Treatment for VeteransNovember 13th, 2026
HHS Announces ARPA-H Awards to Advance Ibogaine Development for PTSD & New $20 Million Funding Opportunity to Advance Rapid-Acting PsychotropicsNovember 13th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
